SANA Insider Trading Activity and SEC Form 4 Filings
SANA insider trading summary
No open-market insider purchases or sales of Sana Biotechnology, Inc. (SANA) have been reported on SEC Form 4 in the past 12 months.
Latest SANA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 8, 2025 | FMR LLC | Insider | Sell | $7K (1,000 @ $7.26) |
| Jan 8, 2025 | FMR LLC | Insider | Sell | $1.1M (164,912 @ $6.71) |
| Jan 8, 2025 | FMR LLC | Insider | Sell | $163K (25,000 @ $6.50) |
| Jan 8, 2025 | FMR LLC | Insider | Sell | $611K (100,000 @ $6.11) |
| Sep 25, 2024 | Richard Mulligan | Insider | Sell | $583K (150,000 @ $3.89) |
| Sep 24, 2024 | Richard Mulligan | Insider | Sell | $613K (150,000 @ $4.08) |
| Mar 8, 2024 | Patrick Y Yang | Insider | Sell | $236K (25,000 @ $9.45) |
| Feb 8, 2024 | Keith Crandell | 10% Owner | Buy | $2.0M (363,637 @ $5.50) |
| Feb 8, 2024 | Clinton Bybee | 10% Owner | Buy | $2.0M (363,637 @ $5.50) |
| Feb 8, 2024 | Robert Nelsen | Director | Buy | $2.0M (363,637 @ $5.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.